380 related articles for article (PubMed ID: 31619447)
1. Anti-NMDAR encephalitis: A single-center, longitudinal study in China.
Xu X; Lu Q; Huang Y; Fan S; Zhou L; Yuan J; Yang X; Ren H; Sun D; Dai Y; Zhu H; Jiang Y; Zhu Y; Peng B; Cui L; Guan H
Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31619447
[TBL] [Abstract][Full Text] [Related]
2. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
Dai Y; Zhang J; Ren H; Zhou X; Chen J; Cui L; Lang J; Guan H; Sun D
Am J Obstet Gynecol; 2019 Nov; 221(5):485.e1-485.e10. PubMed ID: 31128109
[TBL] [Abstract][Full Text] [Related]
3. Clinical features, treatments, and outcomes of patients with anti-
Xu Q; Zhu Y; Wang Q; Han J; Mao F; Zeng S; Chen S; Zhao C; Gu M; Li Z; Luo X; Fu X; Huang Y
Front Biosci (Landmark Ed); 2021 Sep; 26(9):496-503. PubMed ID: 34590462
[No Abstract] [Full Text] [Related]
4. Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan.
Kong SS; Chen YJ; Su IC; Lin JJ; Chou IJ; Chou ML; Hung PC; Hsieh MY; Wang YS; Chou CC; Wang HS; Lin KL;
Pediatr Neonatol; 2019 Aug; 60(4):417-422. PubMed ID: 30449706
[TBL] [Abstract][Full Text] [Related]
5. Anti-N-methyl-D-aspartate receptor encephalitis with accompanying ovarian teratoma in female patients from East China: Clinical features, treatment, and prognostic outcomes.
Zhang L; Lu Y; Xu L; Liu L; Wu X; Zhang Y; Zhu G; Hong Z
Seizure; 2020 Feb; 75():55-62. PubMed ID: 31874360
[TBL] [Abstract][Full Text] [Related]
6. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
[No Abstract] [Full Text] [Related]
8. Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.
Wang Y; Zhang W; Yin J; Lu Q; Yin F; He F; Peng J
J Neuroimmunol; 2017 Nov; 312():59-65. PubMed ID: 28935354
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of clinical characteristics and outcomes of mechanically ventilated patients with anti-N-methyl-D-aspartate receptor encephalitis].
Zhang Y; Su YY; Gao DQ; Ye H
Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):187-192. PubMed ID: 28162168
[No Abstract] [Full Text] [Related]
10. Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
Iizuka T; Kaneko J; Tominaga N; Someko H; Nakamura M; Ishima D; Kitamura E; Masuda R; Oguni E; Yanagisawa T; Kanazawa N; Dalmau J; Nishiyama K
JAMA Neurol; 2016 Jun; 73(6):706-13. PubMed ID: 27111481
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].
Yuan J; Peng B; Guan HZ; Huang Y; Lu Q; Ren HT; Yang XZ; Jiang N; Zhu YC; Cui LY
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1035-9. PubMed ID: 27055797
[TBL] [Abstract][Full Text] [Related]
12. Seizure Characteristics, Outcome, and Risk of Epilepsy in Pediatric Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
Qu XP; Vidaurre J; Peng XL; Jiang L; Zhong M; Hu Y
Pediatr Neurol; 2020 Apr; 105():35-40. PubMed ID: 31917096
[TBL] [Abstract][Full Text] [Related]
13. Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China.
Zhang Y; Liu G; Jiang MD; Li LP; Su YY
Clin Neurophysiol; 2017 Jul; 128(7):1227-1233. PubMed ID: 28527387
[TBL] [Abstract][Full Text] [Related]
14. Teratoma Removal, Steroid, IVIG, Rituximab and Tocilizumab (T-SIRT) in Anti-NMDAR Encephalitis.
Lee WJ; Lee ST; Shin YW; Lee HS; Shin HR; Kim DY; Kim S; Lim JA; Moon J; Park KI; Kim HS; Chu K; Lee SK
Neurotherapeutics; 2021 Jan; 18(1):474-487. PubMed ID: 32880854
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features and Outcomes of Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Infants and Toddlers.
Ren C; Zhang W; Ren X; Li J; Ding C; Wang X; Ren H; Fang F
Pediatr Neurol; 2021 Jun; 119():27-33. PubMed ID: 33838580
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of pediatric Anti-NMDA receptor encephalitis.
Shim Y; Kim SY; Kim H; Hwang H; Chae JH; Choi J; Kim KJ; Yum MS; Ko TS; Kim YO; Byeon JH; Lee J; Lee J; Kim JS; Lim BC
Eur J Paediatr Neurol; 2020 Nov; 29():87-91. PubMed ID: 33046392
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of relapsing anti-N-methyl-D-aspartate receptor encephalitis].
Hongzhi G; Weize K; Bin P; Yan H; Qiang L; Yuan J; Qing L; Hang S; Haitao R; Yicheng Z; Dawei S; Liying C
Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(13):996-1001. PubMed ID: 26506710
[TBL] [Abstract][Full Text] [Related]
18. Pediatric anti-N-methyl-d-aspartate receptor encephalitis in southern China: Analysis of 111 cases.
Li X; Hou C; Wu WL; Liang H; Zheng K; Zhang Y; Zeng Y; Chen L; Zhu H; Tian Y; Gao Y; Peng B; Yang S; Wang X; Ning S; Liao Y; Lin H; Chen WX
J Neuroimmunol; 2021 Mar; 352():577479. PubMed ID: 33486307
[TBL] [Abstract][Full Text] [Related]
19. Anti-NMDAR Encephalitis of 11 Cases in China - Detailed Clinical, Laboratory and Imagiological Description.
Liu J; Wang D; Xiong Y; Liu B; Liu M
Eur Neurol; 2015; 74(1-2):73-8. PubMed ID: 26277996
[TBL] [Abstract][Full Text] [Related]
20. Seizure outcomes in patients with anti-NMDAR encephalitis: A follow-up study.
Liu X; Yan B; Wang R; Li C; Chen C; Zhou D; Hong Z
Epilepsia; 2017 Dec; 58(12):2104-2111. PubMed ID: 29098690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
